Market Overview:
The global qPCR instrument market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for qPCR instruments for drug research, development of new drugs, and clinical diagnosis. Additionally, the rising prevalence of target diseases is also contributing to the growth of this market. North America dominates the global qPCR instrument market and is expected to maintain its dominance during the forecast period.
Product Definition:
Quantitative PCR (qPCR) is a laboratory technique used to amplify and measure the amount of a specific target DNA molecule in a sample. It is based on the polymerase chain reaction (PCR), which amplifies targeted sequences of DNA. qPCR allows for more accurate and precise measurements than traditional gel electrophoresis, making it an important tool for research and diagnostics.
Model Number 96:
The PCR model number 96 is a thermal cycler used for DNA or RNA-based molecular biology research. It's an automated machine that allows researchers to perform multiple tests in a short period of time. The machine consists of four major components, which are the heat block, thermocycler, cover slip warmer and liquid handler.
Model Number 128:
The model number 128 is used to represent the PCR instrument market. It is a generic description of any thermal cycler that includes annealing and extension steps as well as amplification steps. The model number 128 was created by IBM Corporation for their internal use but it got published in the open market after its success in the semiconductor industry.
Besides, factors such as product features, quality, specifications.
Application Insights:
The drug research segment dominated the global qPCR instrument market in 2017. This is attributed to an increase in demand for rapid and sensitive molecular diagnostic tests for clinical trials. Moreover, an increase in funding by governments and private institutions has fueled the development of new drugs. The clinical diagnosis segment is expected to witness a lucrative CAGR during the forecast period owing to its wide application across various disease categories, such as oncology, infectious diseases, genetic diseases & disorders and others.
Clinical diagnosis of cancer using PCR allows detection of tumor at very early stages when treatment with surgery or radiation therapy can still cure the patient (non-metastatic) or prevent metastasis (metastatic). Thusly increasing demand for rapid molecular diagnostic tests that help detect cancer at its early stages will boost growth during this study period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of qPCR manufacturers and suppliers, availability of advanced products, and high investment by public & private entities in R&D. The Asia Pacific is expected to grow at a lucrative CAGR during the forecast period owing to increasing healthcare spending by governments as well as individuals coupled with rising awareness regarding early diagnosis. Moreover, an increase in outsourcing activities from developed countries is anticipated to fuel regional growth over the next eight years.
The Latin American market for qPCR instruments was estimated at USD X million in 2017.
Growth Factors:
- Increasing demand for fast, accurate, and reliable diagnostic tests
- Technological advancements in qPCR instruments and assay development
- Growing number of research institutes and academic centers that are using qPCR technology
- Rising prevalence of target diseases that can be diagnosed through qPCR assays
- Increasing number of biotechnology and pharmaceutical companies that are adopting qPCR technology for drug discovery
Scope Of The Report
Report Attributes
Report Details
Report Title
qPCR Instrument Market Research Report
By Type
Model Number 96, Model Number 128, Other
By Application
Drug Research, Development Of New Drugs, Clinical Diagnosis, Research Institute, Other
By Companies
Agilent Technologies, Bio-Rad Laboratories, QIAGEN, Thermo Fisher Scientific, altona Diagnostics, Cepheid, Roche Diagnostics, Promega, TATAA Biocenter
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global qPCR Instrument Market Report Segments:
The global qPCR Instrument market is segmented on the basis of:
Types
Model Number 96, Model Number 128, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Drug Research, Development Of New Drugs, Clinical Diagnosis, Research Institute, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Agilent Technologies
- Bio-Rad Laboratories
- QIAGEN
- Thermo Fisher Scientific
- altona Diagnostics
- Cepheid
- Roche Diagnostics
- Promega
- TATAA Biocenter
Highlights of The qPCR Instrument Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Model Number 96
- Model Number 128
- Other
- By Application:
- Drug Research
- Development Of New Drugs
- Clinical Diagnosis
- Research Institute
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the qPCR Instrument Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A qPCR instrument is a laboratory tool used to amplify DNA sequences from samples.
Some of the major players in the qpcr instrument market are Agilent Technologies, Bio-Rad Laboratories, QIAGEN, Thermo Fisher Scientific, altona Diagnostics, Cepheid, Roche Diagnostics, Promega, TATAA Biocenter.
The qpcr instrument market is expected to grow at a compound annual growth rate of 10.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. qPCR Instrument Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. qPCR Instrument Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. qPCR Instrument Market - Supply Chain
4.5. Global qPCR Instrument Market Forecast
4.5.1. qPCR Instrument Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. qPCR Instrument Market Size (000 Units) and Y-o-Y Growth
4.5.3. qPCR Instrument Market Absolute $ Opportunity
5. Global qPCR Instrument Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. qPCR Instrument Market Size and Volume Forecast by Type
5.3.1. Model Number 96
5.3.2. Model Number 128
5.3.3. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global qPCR Instrument Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. qPCR Instrument Market Size and Volume Forecast by Application
6.3.1. Drug Research
6.3.2. Development Of New Drugs
6.3.3. Clinical Diagnosis
6.3.4. Research Institute
6.3.5. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global qPCR Instrument Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. qPCR Instrument Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global qPCR Instrument Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. qPCR Instrument Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global qPCR Instrument Demand Share Forecast, 2019-2026
9. North America qPCR Instrument Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America qPCR Instrument Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America qPCR Instrument Market Size and Volume Forecast by Application
9.4.1. Drug Research
9.4.2. Development Of New Drugs
9.4.3. Clinical Diagnosis
9.4.4. Research Institute
9.4.5. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America qPCR Instrument Market Size and Volume Forecast by Type
9.7.1. Model Number 96
9.7.2. Model Number 128
9.7.3. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America qPCR Instrument Demand Share Forecast, 2019-2026
10. Latin America qPCR Instrument Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America qPCR Instrument Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America qPCR Instrument Market Size and Volume Forecast by Application
10.4.1. Drug Research
10.4.2. Development Of New Drugs
10.4.3. Clinical Diagnosis
10.4.4. Research Institute
10.4.5. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America qPCR Instrument Market Size and Volume Forecast by Type
10.7.1. Model Number 96
10.7.2. Model Number 128
10.7.3. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America qPCR Instrument Demand Share Forecast, 2019-2026
11. Europe qPCR Instrument Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe qPCR Instrument Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe qPCR Instrument Market Size and Volume Forecast by Application
11.4.1. Drug Research
11.4.2. Development Of New Drugs
11.4.3. Clinical Diagnosis
11.4.4. Research Institute
11.4.5. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe qPCR Instrument Market Size and Volume Forecast by Type
11.7.1. Model Number 96
11.7.2. Model Number 128
11.7.3. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe qPCR Instrument Demand Share, 2019-2026
12. Asia Pacific qPCR Instrument Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific qPCR Instrument Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific qPCR Instrument Market Size and Volume Forecast by Application
12.4.1. Drug Research
12.4.2. Development Of New Drugs
12.4.3. Clinical Diagnosis
12.4.4. Research Institute
12.4.5. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific qPCR Instrument Market Size and Volume Forecast by Type
12.7.1. Model Number 96
12.7.2. Model Number 128
12.7.3. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific qPCR Instrument Demand Share, 2019-2026
13. Middle East & Africa qPCR Instrument Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa qPCR Instrument Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa qPCR Instrument Market Size and Volume Forecast by Application
13.4.1. Drug Research
13.4.2. Development Of New Drugs
13.4.3. Clinical Diagnosis
13.4.4. Research Institute
13.4.5. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa qPCR Instrument Market Size and Volume Forecast by Type
13.7.1. Model Number 96
13.7.2. Model Number 128
13.7.3. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa qPCR Instrument Demand Share, 2019-2026
14. Competition Landscape
14.1. Global qPCR Instrument Market: Market Share Analysis
14.2. qPCR Instrument Distributors and Customers
14.3. qPCR Instrument Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Agilent Technologies
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Bio-Rad Laboratories
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. QIAGEN
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Thermo Fisher Scientific
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. altona Diagnostics
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Cepheid
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Roche Diagnostics
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Promega
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. TATAA Biocenter
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
